This study states that Endovascular treatment of chronic mesenteric ischemia (CMI) has been shown to have similar perioperative mortality and shorter hospitalization compared with open repair but increased reinterventions due to restenosis. Covered stents (CSs) are associated with less restenosis, recurrence of symptoms, and reinterventions than bare-metal uncovered stents (UCSs). This study intends to revisit endovascular management of CMI and to evaluate differences in patients who received CSs or UCSs.

Clinical data were obtained retrospectively for CMI patients at a single center from 2010 to 2015. Patients included were treated with either UCS or CS, were diagnosed with CMI, and had radiographic evidence of mesenteric disease. Patients who were excluded had acute mesenteric ischemia or procedures performed at an outside hospital. Sixty patients with an average age of 70.7 ± 9.4 years were involved in the study. Comorbidities included type 2 diabetes (21/60), hypertension (51/60), hyperlipidemia (51/60), and smoking history (52/60; Table I). Fisher exact test was performed, and there was a difference between the specific mesenteric vessel intervention completed and the number of diseased mesenteric vessels. 

Reference link-https://www.jvascsurg.org/article/S0741-5214(20)31491-9/fulltext